"Autoantigens" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Endogenous tissue constituents that have the ability to interact with AUTOANTIBODIES and cause an immune response.
| Descriptor ID |
D001324
|
| MeSH Number(s) |
D23.050.422
|
| Concept/Terms |
Autoantigens- Autoantigens
- Autologous Antigens
- Antigens, Autologous
- Self-Antigens
- Self Antigens
|
Below are MeSH descriptors whose meaning is more general than "Autoantigens".
Below are MeSH descriptors whose meaning is more specific than "Autoantigens".
This graph shows the total number of publications written about "Autoantigens" by people in this website by year, and whether "Autoantigens" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 0 | 1 | 1 |
| 2000 | 1 | 0 | 1 |
| 2005 | 1 | 0 | 1 |
| 2007 | 2 | 0 | 2 |
| 2009 | 2 | 1 | 3 |
| 2010 | 0 | 1 | 1 |
| 2012 | 0 | 1 | 1 |
| 2014 | 1 | 1 | 2 |
| 2015 | 0 | 2 | 2 |
| 2016 | 1 | 1 | 2 |
| 2017 | 10 | 28 | 38 |
| 2018 | 12 | 16 | 28 |
| 2019 | 3 | 10 | 13 |
| 2020 | 0 | 5 | 5 |
| 2021 | 2 | 1 | 3 |
To return to the timeline, click here.
Below are the most recent publications written about "Autoantigens" by people in Profiles.
-
Adaptive Immunity and the Risk of Autoreactivity in COVID-19. Int J Mol Sci. 2021 Aug 20; 22(16).
-
Myasthenia gravis associated with novel coronavirus 2019 infection: A report of three cases. Clin Neurol Neurosurg. 2021 Sep; 208:106834.
-
Myocarditis With COVID-19 mRNA Vaccines. Circulation. 2021 08 10; 144(6):471-484.
-
Acute autoimmune-like hepatitis with atypical anti-mitochondrial antibody after mRNA COVID-19 vaccination: A novel clinical entity? J Autoimmun. 2021 09; 123:102706.
-
Untangling COVID-19 and autoimmunity: Identification of plausible targets suggests multi organ involvement. Mol Immunol. 2021 09; 137:105-113.
-
Enhanced Expression of Autoantigens During SARS-CoV-2 Viral Infection. Front Immunol. 2021; 12:686462.
-
Unique autoantibody prevalence in long-term recovered SARS-CoV-2-infected individuals. J Autoimmun. 2021 08; 122:102682.
-
Genes with 5' terminal oligopyrimidine tracts preferentially escape global suppression of translation by the SARS-CoV-2 Nsp1 protein. RNA. 2021 09; 27(9):1025-1045.
-
Autoantibodies against ACE2 and angiotensin type-1 receptors increase severity of COVID-19. J Autoimmun. 2021 08; 122:102683.
-
How Children Are Protected From COVID-19? A Historical, Clinical, and Pathophysiological Approach to Address COVID-19 Susceptibility. Front Immunol. 2021; 12:646894.